Back-up bone marrow is frequently ineffective in patients with poor peripheral-blood stem-cell mobilization. [electronic resource]
Producer: 19980512Description: 1554-60 p. digitalISSN:- 0732-183X
- Adolescent
- Adult
- Aged
- Antigens, CD34 -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Blood Cell Count
- Blood Transfusion
- Bone Marrow -- metabolism
- Carmustine -- therapeutic use
- Combined Modality Therapy
- Cryopreservation
- Cyclophosphamide -- administration & dosage
- Cytarabine -- therapeutic use
- Female
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Hematopoietic Stem Cell Mobilization -- methods
- Hematopoietic Stem Cell Transplantation
- Humans
- Male
- Melphalan -- therapeutic use
- Middle Aged
- Neoplasms -- blood
- Podophyllotoxin -- therapeutic use
- Treatment Failure
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.